Brief: Aquestive Therapeutics Inc Reports Positive Topline Data From Temperature / pH Study Of Anaphylm™ (Epinephrine) Sublingual Film
25/06/2024 13:37
June 25 (Reuters) - Aquestive Therapeutics Inc AQST.O :
* AQUESTIVE THERAPEUTICS INC: REPORTS POSITIVE TOPLINE DATA
FROM
TEMPERATURE / PH STUDY OF ANAPHYLM™ (EPINEPHRINE) SUBLINGUAL
FILM
* AQUESTIVE THERAPEUTICS INC: ON TRACK TO COMPLETE ANAPHYLM
SUPPORTIVE CLINICAL STUDIES, EXPECTS TO REQUEST PRE-NDA MEETING
WITH FDA IN Q3
* AQUESTIVE THERAPEUTICS: SEES FILING NDA SHORTLY AFTER
COMPLETION
OF PEDIATRIC STUDY OF ANAPHYLM
Source text for Eikon: ID:nGNX54XGyv
Further company coverage: AQST.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aquestive Therapeutics
See all newsBrief: Aquestive Therapeutics Announces FDA Acceptance Of Anaphylm™ NDA Resubmission And PDUFA Goal Date Of March 16, 2027
US STOCKS ON THE MOVE-Netflix, Coinbase Global, Accenture
US STOCKS ON THE MOVE-Bending Spoons, Skydance, Albertsons
US STOCKS ON THE MOVE-Albertsons, GlobalFoundries, American Electric Power, Fastenal
Aquestive rises on US licensing deal for seizure drug with Eton Pharma